(Q40630628)

22 September 2017

title

Comparative efficacy of intramuscular artemether and intravenous quinine in Nigerian children with cerebral malaria (English)

1 reference

22 September 2017

0 references

0 references

1 reference

4

1 reference

22 September 2017

Olumese PE

1

1 reference

22 September 2017

Björkman A

series ordinal

2

1 reference

22 September 2017

Gbadegesin RA

series ordinal

3

1 reference

22 September 2017

Walker O

series ordinal

5

1 reference

22 September 2017

publication date

1 October 1999

1 reference

22 September 2017

1 reference

22 September 2017

volume

73

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

231-236

1 reference

Comparative efficacy of halofantrine, chloroquine and sulfadoxine-pyrimethamine for treatment of acute uncomplicated falciparum malaria in Nigerian children

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900031-5

Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900031-5

Indicators of life-threatening malaria in African children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900031-5

An open randomized trial of artemether versus quinine in the treatment of cerebral malaria in African children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900031-5

Respiratory distress adversely affects the outcome of childhood cerebral malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900031-5

In-vitro chloroquine and mefloquine-resistant Plasmodium falciparum in Nigeria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900031-5

Evaluation of the sensitivity in vivo and in vitro of Plasmodium falciparum malaria to quinine in an area of full sensitivity to chloroquine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900031-5

Evaluation of the clinical efficacy and safety of halofantrine in falciparum malaria in Ibadan, Nigeria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900031-5

Rapid coma resolution with artemether in Malawian children with cerebral malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900031-5

A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900031-5

A trial of artemether or quinine in children with cerebral malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900031-5

Prognostic risk factors and post mortem findings in cerebral malaria in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900031-5

An open randomized comparative study of intramuscular artemether and intravenous quinine in cerebral malaria in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900031-5

10.1016/S0001-706X(99)00031-5

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference